A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Lupus Nephritis
Related studies linked through entity extraction aliases.
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1
Fibrinogen to Albumin Ratio (FAR) as a Predictive Biomarker for Lupus Nephritis (LN)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
- Status
- RECRUITING
- Phase
- PHASE1
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
- Status
- RECRUITING
- Phase
- NA
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Wellness & Workforce Solution for Lupus/Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
- Status
- RECRUITING
- Phase
- N/A
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Assessment of Safety and Efficacy of SGLT2is Among LN Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
RY_SW01 Cell Injection Therapy in Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
- Status
- UNKNOWN
- Phase
- N/A
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2